Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
PLoS One ; 15(6): e0234920, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32559224

RESUMEN

Sanguinarine is a bioactive compound as a quaternary benzophenanthridine alkaloid from plant of the Macleaya cordata, Papaveraceae family. The present study was conducted to investigate the effects of dietary sanguinarine supplementation on growth performance, serum biochemistry parameters, intestinal mucosal morphology and gut microbiome in yellow feathered broilers. Two hundred and seventy 1-d-old female broilers were randomly assigned to 3 treatments ① Basal diet (NG); ② Basal diet containing bacitracin methylene disalicylate (50mg/Kg diet) (ANT); ③ Basal diet containing sanguinarine (0.7 mg/ kg of feed) (SAG). The statistical results showed that dietary sanguinarine supplementation enhanced growth performance and decreased glucose, uric acid as well as urea nitrogen levels of broilers at 28d of age (P<0.05). The 16S rRNA gene sequence analysis revealed that sanguinarine significantly decreased the species from the phyla Bacteroidetes, and increased the species from phyla Firmicutes. Moreover, dietary sanguinarine supplementation improved mucosal morphology to achieve higher ratio of intestinal villus height to crypt depth (P < 0.05), and decreased the concentrations of TNF-α and IL-4 in jejunum mucosal. This study demonstrated that sanguinarine supplementation in the diet of yellow feathered broilers improved intestinal morphology and microbiota community structure to promote growth performance on 1-28d.


Asunto(s)
Antiinfecciosos/farmacología , Benzofenantridinas/farmacología , Pollos/microbiología , Microbioma Gastrointestinal , Isoquinolinas/farmacología , Yeyuno/efectos de los fármacos , Animales , Antiinfecciosos/administración & dosificación , Proteínas Aviares/genética , Proteínas Aviares/metabolismo , Bacteroidetes/efectos de los fármacos , Bacteroidetes/patogenicidad , Benzofenantridinas/administración & dosificación , Glucemia/metabolismo , Pollos/crecimiento & desarrollo , Suplementos Dietéticos , Femenino , Firmicutes/efectos de los fármacos , Firmicutes/patogenicidad , Interleucina-4/genética , Interleucina-4/metabolismo , Isoquinolinas/administración & dosificación , Yeyuno/crecimiento & desarrollo , Yeyuno/metabolismo , Yeyuno/microbiología , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/metabolismo , Ácido Úrico/sangre
2.
Sci Rep ; 9(1): 14150, 2019 10 02.
Artículo en Inglés | MEDLINE | ID: mdl-31578395

RESUMEN

The vascular dysfunction is the primary event in the occurrence of cardio-vascular risk, and no treatment exists until now. We tested for the first time the hypothesis that chitin-glucan (CG) - an insoluble fibre with prebiotic properties- and polyphenol-rich pomegranate peel extract (PPE) can improve endothelial and inflammatory disorders in a mouse model of cardiovascular disease (CVD), namely by modulating the gut microbiota. Male Apolipoprotein E knock-out (ApoE-/-) mice fed a high fat (HF) diet developed a significant endothelial dysfunction attested by atherosclerotic plaques and increasing abundance of caveolin-1 in aorta. The supplementation with CG + PPE in the HF diet reduced inflammatory markers both in the liver and in the visceral adipose tissue together with a reduction of hepatic triglycerides. In addition, it increased the activating form of endothelial NO-synthase in mesenteric arteries and the heme-nitrosylated haemoglobin (Hb-NO) blood levels as compared with HF fed ApoE-/- mice, suggesting a higher capacity of mesenteric arteries to produce nitric oxide (NO). This study allows to pinpoint gut bacteria, namely Lactobacillus and Alistipes, that could be implicated in the management of endothelial and inflammatory dysfunctions associated with CVD, and to unravel the role of nutrition in the modulation of those bacteria.


Asunto(s)
Antiinflamatorios/farmacología , Aterosclerosis/prevención & control , Endotelio Vascular/metabolismo , Microbioma Gastrointestinal/efectos de los fármacos , Polifenoles/farmacología , Polisacáridos/farmacología , Granada (Fruta)/química , Animales , Antiinflamatorios/uso terapéutico , Aorta/metabolismo , Aorta/patología , Apolipoproteínas E/genética , Aterosclerosis/etiología , Aterosclerosis/microbiología , Bacteroidetes/efectos de los fármacos , Bacteroidetes/patogenicidad , Caveolina 1/metabolismo , Dieta Alta en Grasa/efectos adversos , Lactobacillus/efectos de los fármacos , Lactobacillus/patogenicidad , Masculino , Arterias Mesentéricas/metabolismo , Arterias Mesentéricas/patología , Ratones , Óxido Nítrico Sintasa de Tipo III/metabolismo , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Polifenoles/uso terapéutico , Polisacáridos/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA